CBD is not a scheduled substance in Switzerland, and its legality in the finished product depends on the intended use. This inevitably leads to a somewhat confusing regulatory framework with many different rules and restrictions ...
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sectors, with a focus on non-US markets. Most content is available to subscribers only.